EUVIMEDEUVIMED entdecken
Crossref

Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status

Mitsuhiro Kanamori, Hiroko Nakatsukasa, Minako Ito, Shunsuke Chikuma, Akihiko Yoshimura

International Immunology · 24.07.2018 · 30 (8) · 357-373

DOI: 10.1093/intimm/dxy043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 02.07.2018. Verfasst von Mitsuhiro Kanamori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Cellular Reprogramming. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: JSPS KAKENHI, Advanced Research & Development Programs for Medical Innovation, Grant-in-Aid for Young Scientists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T helper type 1 (Th1) cells form one of the most stable CD4 T-cell subsets, and direct conversion of fully differentiated Th1 to regulatory T (Treg) cells has been poorly investigated. Here, we established a culture method for inducing Foxp3 from Th1 cells of mice and humans. This is achieved simply by resting Th1 cells without T-cell receptor ligation before stimulation in the presence of transforming growth factor-beta (TGF-β). We named the resulting Th1-derived Foxp3+ cells Th1reg cells. Mouse Th1reg cells showed an inducible Treg-like phenotype and suppressive ability both in vitro and in vivo. Th1reg cells could also be induced from in vivo-developed mouse Th1 cells. Unexpectedly, the resting process enabled Foxp3 expression not through epigenetic changes at the locus, but through metabolic change resulting from reduced mammalian target of rapamycin complex 1 (mTORC1) activity. mTORC1 suppressed TGF-β-induced phosphorylation of Smad2/3 in Th1 cells, which was restored in rested cells. Our study warrants future research aiming at development of immunotherapy with Th1reg cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular ReprogrammingAdultAnimalsHumansMaleMiceMice, Inbred BALB CMice, Inbred C57BLT-Lymphocytes, RegulatoryTh1 Cells

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Förderung

  • JSPS KAKENHI
  • Advanced Research & Development Programs for Medical Innovation
  • Grant-in-Aid for Young Scientists
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Uehara Memorial Foundation
  • Kanae Foundation
  • SENSHIN Medical Research Foundation

Zitieren

APA

Kanamori, M., Nakatsukasa, H., Ito, M., Chikuma, S., & Yoshimura, A. (2018). Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status. International Immunology, 30(8), 357-373. https://doi.org/10.1093/intimm/dxy043

Vancouver

Kanamori M, Nakatsukasa H, Ito M, Chikuma S, Yoshimura A. Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status. International Immunology. 2018;30(8):357-373. doi:10.1093/intimm/dxy043

BibTeX
@article{Kanamori2018,
  author = {Kanamori, Mitsuhiro and Nakatsukasa, Hiroko and Ito, Minako and Chikuma, Shunsuke and Yoshimura, Akihiko},
  title = {Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status},
  journal = {International Immunology},
  year = {2018},
  volume = {30},
  number = {8},
  pages = {357--373},
  doi = {10.1093/intimm/dxy043}
}
Kostenlos starten →